Skip to main content
. 2021 Apr 15;35(10):1428–1441. doi: 10.1177/02692155211010369

Table 3.

Mean difference for each outcome between the groups (control compared with intervention) at start-of-treatment, follow-up two-months and follow-up eight-months using a linear mixed model for repeated measurements.

Measure Mean difference (95% CI) between groups, start of treatment P-value Mean difference (95% CI) between groups, two-months follow-up P-value Mean difference (95% CI) between groups, eight-months follow-up P-value
MCS −1.27 (−4.67 to 2.13) 0.464 −1.93 (−5.43 to 1.57) 0.280 −0.61 (−4.11 to 2.90) 0.734
CGB −0.01 (−0.34 to 0.21) 0.632 0.07 (−0.21 to 0.34) 0.633 −0.01 (−0.29 to 0.26) 0.920
FACES 0.15 (−0.25 to 0.55) 0.470 0.03 (−0.38 to 0.21) 0.871 0.15 (−0.26 to 0.56) 0.482
FCS 4.36 (−0.26 to 0.56) 0.331 −1.81 (−4.42 to 13.14) 0.692 2.75 (−10.77 to 7.14) 0.548
FSS 3.47 (−6.49 to 13.43) 0.495 −0.19 (−10.37 to 10.00) 0.972 1.13 (−9.09 to 11.35) 0.828
QOLIBRI −2.23 (−10.58 to 6.12) 0.601 0.88 (−7.59 to 9.35) 0.838 1.10 (−7.37 to 9.56) 0.799

MCS: mental component summary; CGB: caregiver burden scale; FACES: family adaptability and cohesion evaluation scale; FCS: family communication scale; FSS: family satisfaction scale; QOLIBRI: quality of life after brain injury questionnaire.